Association of Plasma Levels of Angiotensin-Converting Enzyme and Cytokines with Recurrent Depression : A Preliminary Study

안지오텐신전환효소 및 사이토카인 혈장 레벨과 재발성 우울증의 연관성 : 예비 연구

  • Sohn, Hoyoung (Department of Psychiatry, CHA Bundang Medical Center, CHA University) ;
  • Lee, Sun-Woo (Department of Psychiatry, CHA Bundang Medical Center, CHA University) ;
  • Kim, Min-Kyoung (Department of Psychiatry, CHA Bundang Medical Center, CHA University) ;
  • Lee, Kang Soo (Department of Psychiatry, CHA Bundang Medical Center, CHA University) ;
  • Lee, Sang-Hyuk (Department of Psychiatry, CHA Bundang Medical Center, CHA University) ;
  • Kwon, Min-Soo (Department of Pharmacology, School of Medicine, CHA University) ;
  • Kim, Borah (Department of Psychiatry, CHA Bundang Medical Center, CHA University)
  • 손호영 (차의과학대학교 분당차병원 정신건강의학과) ;
  • 이선우 (차의과학대학교 분당차병원 정신건강의학과) ;
  • 김민경 (차의과학대학교 분당차병원 정신건강의학과) ;
  • 이강수 (차의과학대학교 분당차병원 정신건강의학과) ;
  • 이상혁 (차의과학대학교 분당차병원 정신건강의학과) ;
  • 권민수 (차의과대학교 의학전문대학원 약리학교실) ;
  • 김보라 (차의과학대학교 분당차병원 정신건강의학과)
  • Received : 2016.12.07
  • Accepted : 2017.01.23
  • Published : 2017.02.28

Abstract

Objectives Angiotensin-converting enzyme (ACE) gene and plasma levels of cytokines, such as tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$), interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-10 (IL-10), have previously been determined to be associated with depression. The purpose of this study was to investigate the association of plasma levels of ACE and cytokines with recurrent depression. Methods A total of 52 participants (14 male, 38 female, aged $43.9{\pm}14.0years$) were enrolled after being diagnosed with depression by experienced psychiatrists using the Mini International Neuropsychiatric Interview from the outpatient clinic of the Department of Psychiatry, CHA Bundang Medical Center. The participants completed blood sampling, the Hamilton Depression Rating Scale (HAMD), the Beck Depression Inventory, the Beck Anxiety Inventory, and the Scale for Suicidal Ideation. Results ACE plasma levels are higher in patients with recurrent depression ($27.4{\pm}10.4U/L$) than in patients with newly diagnosed depression ($19.1{\pm}7.7U/L$) (p = 0.004). The levels of cytokines, such as $TNF-{\alpha}$, IL-4, IL-6, IL-10, are not significantly different between the two groups. Additionally, the ACE plasma level is negatively correlated with a reduction in the HAMD over six weeks (r = -0.429, p = 0.046, n = 22). Conclusions The current findings show that plasma ACE levels may be associated with recurrent depression and further suggest that the renin-angiotensin system could play a role in recurrent depression.

Keywords

References

  1. Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 2008;69 Suppl E1:4-7. https://doi.org/10.4088/JCP.0208e04
  2. Ancelin ML, Carriere I, Scali J, Ritchie K, Chaudieu I, Ryan J. Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression. Transl Psychiatry 2013;3:e322. https://doi.org/10.1038/tp.2013.95
  3. Armando I, Volpi S, Aguilera G, Saavedra JM. Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res 2007;1142:92-99. https://doi.org/10.1016/j.brainres.2007.01.037
  4. Arinami T, Li L, Mitsushio H, Itokawa M, Hamaguchi H, Toru M. An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol Psychiatry 1996;40:1122-1127. https://doi.org/10.1016/S0006-3223(95)00597-8
  5. Hui L, Wu JQ, Ye MJ, Zheng K, He JC, Zhang X, et al. Association of angiotensin-converting enzyme gene polymorphism with schizophrenia and depressive symptom severity in a Chinese population. Hum Psychopharmacol 2015;30:100-107. https://doi.org/10.1002/hup.2460
  6. Stewart JA, Kampman O, Huuhka M, Anttila S, Huuhka K, Lehtimaki T, et al. ACE polymorphism and response to electroconvulsive therapy in major depression. Neurosci Lett 2009;458:122-125. https://doi.org/10.1016/j.neulet.2009.04.057
  7. McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, Julier C, et al. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 2001;10:1077-1084. https://doi.org/10.1093/hmg/10.10.1077
  8. McKenzie CA, Julier C, Forrester T, McFarlane-Anderson N, Keavney B, Lathrop GM, et al. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 1995;57:1426-1435.
  9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346. https://doi.org/10.1172/JCI114844
  10. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
  11. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001;68:1139-1148. https://doi.org/10.1086/320104
  12. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016;16:22-34. https://doi.org/10.1038/nri.2015.5
  13. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-457. https://doi.org/10.1016/j.biopsych.2009.09.033
  14. Han A, Yeo H, Park MJ, Kim SH, Choi HJ, Hong CW, et al. IL-4/10 prevents stress vulnerability following imipramine discontinuation. J Neuroinflammation 2015;12:197. https://doi.org/10.1186/s12974-015-0416-3
  15. Hodes GE, Pfau ML, Leboeuf M, Golden SA, Christoffel DJ, Bregman D, et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci U S A 2014;111:16136-16141. https://doi.org/10.1073/pnas.1415191111
  16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association;2000.
  17. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33;quiz 34-57.
  18. Yoo SW, Kim YS, Noh JS, Oh KS, Kim CH, Namkoong K, et al. Validity of Korean version of the mini-international neuropsychiatric interview. Anxiety Mood 2006;2:50-55.
  19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62. https://doi.org/10.1136/jnnp.23.1.56
  20. Yi JS, Bae SO, Ahn YM, Park DB, Noh KS, Shin HK, et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS). J Korean Neuropsychiatr Assoc 2005;44:456-465.
  21. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571. https://doi.org/10.1001/archpsyc.1961.01710120031004
  22. Lee YH, Song JY. A study of the reliability and the validity of the BDI, SDS, and MMPI-D scales. Korean J Clin Psychol 1991;10:98-113.
  23. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893. https://doi.org/10.1037/0022-006X.56.6.893
  24. Yook SP, Kim ZS. A clinical study on the Korean version of Beck anxiety inventory: comparative study of patient and non-patient. Korean J Clin Psychol 1997;16:185-197.
  25. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the scale for suicide ideation. J Consult Clin Psychol 1979;47:343-352. https://doi.org/10.1037/0022-006X.47.2.343
  26. Shin MS. An empirical study of the mechanism of suicide: validation of the scale for escape from the self [dissertation]. Seoul: Yonsei University;1992.
  27. Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord 2015;180:179-184. https://doi.org/10.1016/j.jad.2015.03.021
  28. Beneteau B, Baudin B, Morgant G, Giboudeau J, Baumann FC. Automated kinetic assay of angiotensin-converting enzyme in serum. Clin Chem 1986;32:884-886.
  29. Hurst PL, Lovell-Smith CJ. Optimized assay for serum angiotensin-converting enzyme activity. Clin Chem 1981;27:2048-2052.
  30. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975;59:365-372. https://doi.org/10.1016/0002-9343(75)90395-2
  31. Ronca-Testoni S. Direct spectrophotometric assay for angiotensinconverting enzyme in serum. Clin Chem 1983;29:1093-1096.
  32. Thomas L. Labor und diagnose. Frankfurt: TH Books Verlag Ges.; 2000. p.53-56.
  33. Cusin C, Yang H, Yeung A, Fava M. Rating scales for depression. In: Baer L, Blais MA, editors. Handbook of clinical rating scales and assessment in psychiatry and mental health. New York: Humana Press;2010. p.14.
  34. Saab YB, Gard PR, Yeoman MS, Mfarrej B, El-Moalem H, Ingram MJ. Renin-angiotensin-system gene polymorphisms and depression. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1113-1118. https://doi.org/10.1016/j.pnpbp.2007.04.002
  35. Rodriguez-Perez AI, Borrajo A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Interaction between NADPH-oxidase and rho-kinase in angiotensin II-induced microglial activation. Glia 2015;63:466-482. https://doi.org/10.1002/glia.22765
  36. Smith AK, Maloney EM, Falkenberg VR, Dimulescu I, Rajeevan MS. An angiotensin-1 converting enzyme polymorphism is associated with allostatic load mediated by C-reactive protein, interleukin-6 and cortisol. Psychoneuroendocrinology 2009;34:597-606. https://doi.org/10.1016/j.psyneuen.2008.10.022
  37. Bortolato B, Miskowiak KW, Kohler CA, Maes M, Fernandes BS, Berk M, et al. Cognitive remission: a novel objective for the treatment of major depression? BMC Med 2016;14:9. https://doi.org/10.1186/s12916-016-0560-3
  38. Benicky J, Sanchez-Lemus E, Honda M, Pang T, Orecna M, Wang J, et al. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 2011;36:857-870. https://doi.org/10.1038/npp.2010.225
  39. Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011;36:2452-2459. https://doi.org/10.1038/npp.2011.132
  40. Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, et al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2012;2:e199.
  41. Voorhees JL, Tarr AJ, Wohleb ES, Godbout JP, Mo X, Sheridan JF, et al. Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10. PLoS One 2013;8:e58488. https://doi.org/10.1371/journal.pone.0058488
  42. Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 2014;169:15-20. https://doi.org/10.1016/j.jad.2014.07.032
  43. Talarowska M, Szemraj J, Galecki P. The role of interleukin genes in the course of depression. Open Med 2016;11:41-48.